The Influence of a Single Nucleotide Polymorphism within CNDP1 on Susceptibility to Diabetic Nephropathy in Japanese Women with Type 2 Diabetes

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Kurashige, Mahiro ^a,b   Imamura, Minako ^a   Araki, Shin Ichi ^c   Suzuki, Daisuke ^d   Babazono, Tetsuya ^e   Uzu, Takashi ^c   Umezono, Tomoya ^d   Toyoda, Masao ^d   Kawai, Koichi ^f   Imanishi, Masahito ^g   Hanaoka, Kazushige ^b   Maegawa, Hiroshi ^c   Uchigata, Yasuko ^e   Hosoya, Tatsuo ^b   Maeda, Shiro ^a  

^a RIKEN   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^f Kawai Clinic   (Japan)

^g OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CNDP1 GENE; CNDP2 GENE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; JAPANESE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIPEPTIDASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINURIA;

EID: 84872482524     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054064     Document Type: Article

References (26)

1. ERA-EDTA Registry committee (2012) ERA-EDTA Registry Annual Report 2010. Amsterdam: Academic Medical Center.
2. Nakai S, Iseki K, Itami N, Ogata S, Kazama JJ, et al. (2012) Overview of regular dialysis treatment in Japan (as of 31 December 2009). Ther Apher Dial 16: 11-53.
3. Maeda S, (2008) Genetics of diabetic nephropathy. Ther Adv Cardiovasc Dis 2: 363-371.
4. Vardarli I, Baier LJ, Hanson RL, Akkoyun I, Fischer C, et al. (2002) Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int 62: 2176-2183.
5. Janssen B, Hohenadel D, Brinkkoetter P, Peters V, Rind N, et al. (2005) Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes 54: 2320-2327.
6. Mozdzan M, Szemraj J, Rysz J, Nowak D, (2005) Antioxidant properties of carnosine re-evaluated with oxidizing systems involving iron and copper ions. Basic Clin Pharmacol Toxicol 96: 352-360.
7. Hobart LJ, Seibel I, Yeargans GS, Seidler NW, (2004) Anti-crosslinking properties of carnosine: significance of histidine. Life Sci 75: 1379-1389.
8. Hou WC, Chen HJ, Lin YH, (2003) Antioxidant peptides with angiotensin converting enzyme inhibitory activities and applications for angiotensin converting enzyme purification. J Agric Food Chem 51: 1706-1709.
9. Riedl E, Pfister F, Braunagel M, Brinkkötter P, Sternik P, et al. (2011) Carnosine prevents apoptosis of glomerular cells and podocyte loss in STZ diabetic rats. Cell Physiol Biochem 28: 279-288.
10. Freedman BI, Hicks PJ, Sale MM, Pierson ED, Langefeld CD, et al. (2007) A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans. Nephrol Dial Transplant 22: 1131-1135.
11. Wanic K, Placha G, Dunn J, Smiles A, Warram JH, et al. (2008) Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: results of large case-control and follow-up studies. Diabetes 57: 2547-2551.
12. McDonough CW, Hicks PJ, Lu L, Langefeld CD, Freedman BI, et al. (2009) The influence of carnosinase gene polymorphism on diabetic nephropathy risk in African-Americans. Hum Genet 126: 265-275.
13. Mooyaart AL, Zutinic A, Bakker SJ, Grootendorst DC, Kleefstra N, et al. (2010) Association between CNDP1 genotype and diabetic nephropathy is sex specific. Diabetes 59: 1555-1559.
14. Ahluwalia TS, Lindholm E, Groop LC, (2011) Common variants in CNDP1 and CNDP2, and risk of nephropathy in type 2 diabetes. Diabetologia 54: 2295-2302.
15. Ohnishi Y, Tanaka T, Ozaki K, Yamada R, Suzuki H, et al. (2001) A high-throughput SNP typing system for genome-wide association studies. J Hum Genet 46: 471-477.
16. Mooyaart AL, Valkengoed IG, Shaw PK, Peters V, Baelde HJ, et al. (2009) Lower frequency of the 5/5 homozygous CNDP1 genotype in South Asian Surinamese. Diabetes Res and Clin Prac 85: 272-278.
17. Bowden DW, Colicigno CJ, Langefeld CD, Sale MM, Williams A, et al. (2004) A genome scan for diabetic nephropathy in African Americans. Kidney Int 66: 1517-1526.
18. Iyengar SK, Abboud HE, Goddard KA, Saad MF, Adler SG, et al. (2007) Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND). Diabetes 56: 1577-1585.
19. Teufel M, Saudek V, Ledig JP, Bernhardt A, Boularand S, et al. (2003) Sequence identification and characterization of human carnosinase and closely related non-specific dipeptidase. J Biol Chem 278: 6521-6531.
20. Riedl E, Koeppel H, Brinkkoetter P, Sternik P, Steinbeisser H, et al. (2007) A CTG polymorphism in the CNDP1 gene determines the secretion of serum carnosinase in Cos-7-transfected cells. Diabetes 56: 2410-2413.
21. Poon PY, Szeto CC, Kwan BC, Chow KM, Li PK, (2010) Relationship between carnosinase gene CNDP1 leucine repeat polymorphism and the clinical outcome of Chinese PD patients. Clin Nephrol 74: 343-345.
22. Krolewski AS, Poznik GD, Placha G, Canani L, Dunn J, et al. (2006) A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes. Kidney Int 69: 129-136.
23. Alkhalaf A, Bakker SJ, Bilo HJ, Gans RO, Navis GJ, et al. (2010) A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type1 diabetes mellitus. Diabetologia 53: 2562-2568.
24. Baguet A, Everaert I, Achten E, Thomis M, Derave W, (2012) The influence of sex, age and heritability on human skeletal muscle carnosine content. Amino Acids 43: 13-20.
25. Peñafiel R, Ruzafa C, Monserrat F, Cremades A, (2004) Gender-related differences in carnosine, anserine and lysine content of murine skeletal muscle. Amino Acid 26: 53-58.
26. Chakkera HA, Hanson RL, Kobes S, Millis MP, Nelson RG, et al. (2011) Association of variants in the carnosine peptidase 1 gene (CNDP1) with diabetic nephropathy in American Indians. Mol Genet Metab 103: 185-190.